ARCHIVES

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

This article is from The Cancer Letter archive.

Vol. 05 No. 40 | October 5, 1979

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

More DCT Concepts Approved By Advisors

July 10, 1992

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008